---
tags: [gsdose]
max_turns: 40
timeout_seconds: 1200
allowed_tools: [Read, Glob, Grep, Skill, Write, Edit, Bash]
---

I'm designing a seamless phase 2/3 oncology trial and want to use the gsDose R package (it's installed, along with gsDesign2 and jsonlite; R and Python are available). Please calculate the group sequential efficacy boundaries at the design stage and give me the full output bundle: a Word report, results in JSON, and a standalone R script that reproduces the numbers. I'm not available for back-and-forth, so here is everything upfront — don't ask me questions, just proceed:

- 3 dose arms vs control; exactly one dose will be selected at IA1 (the dose-selection interim — no efficacy testing there)
- Endpoint: OS. Three testing analyses: IA2, IA3, FA (the dose-selection IA1 is not counted)
- Design stage — no analyses have occurred yet
- Planned OS events (selected dose arm + control, both cohorts combined): 260 at IA2, 416 at IA3, 520 at FA
- Cohort 1 is 60 patients (selected dose + control enrolled before dose selection) out of 700 total for those two arms; randomization 1:1. Use cohort weights h = (sqrt(60/700), sqrt(640/700)), the same at every analysis
- Stage weights w: no preference — derive them from expected events. Assumptions: control median OS 33 months, hazard ratio 0.74 (same for all dose arms), no dropout. Enrollment for the selected dose + control arms: rates (10/3, 16/3, 8, 12, 0, 18, 25, 23) patients/month over consecutive periods of (2, 2, 2, 4, 4, 8, 18, 1) months; cohort 1 is the first 8 months of that ramp (rates 10/3, 16/3, 8, 12)
- One-sided alpha 0.025, O'Brien-Fleming spending function; no futility bound
